Barclays’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1K | Hold |
355
| – | – | ﹤0.01% | 4292 |
|
|
2025
Q1 | $1K | Hold |
355
| – | – | ﹤0.01% | 4306 |
|
|
2024
Q4 | $1K | Hold |
355
| – | – | ﹤0.01% | 4324 |
|
|
2024
Q3 | $2K | Buy |
+355
| New | +$2K | ﹤0.01% | 4234 |
|
|
2024
Q1 | – | Sell |
-971
| Closed | -$6K | – | 4188 |
|
|
2023
Q4 | $6K | Sell |
971
-317
| -25% | -$1.96K | ﹤0.01% | 4070 |
|
|
2023
Q3 | $4K | Buy |
+1,288
| New | +$4K | ﹤0.01% | 4129 |
|
|
2022
Q3 | – | Sell |
-1
| Closed | – | – | 4693 |
|
|
2022
Q2 | $0 | Sell |
1
-111
| -99% | – | ﹤0.01% | 4765 |
|
|
2022
Q1 | $1K | Buy |
+112
| New | +$1K | ﹤0.01% | 4705 |
|
|
2021
Q4 | – | Sell |
-77,300
| Closed | -$618K | – | 3380 |
|
|
2021
Q3 | $618K | Buy |
+77,300
| New | +$618K | ﹤0.01% | 2498 |
|